Privia Health Group (NASDAQ:PRVA – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $422.01 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.
Privia Health Group Stock Performance
Shares of NASDAQ:PRVA opened at $24.53 on Wednesday. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $25.67. The firm has a market capitalization of $2.94 billion, a P/E ratio of 245.32, a P/E/G ratio of 3.47 and a beta of 0.87. The stock has a 50 day moving average price of $22.12 and a 200-day moving average price of $20.49.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on PRVA shares. Macquarie assumed coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective for the company. Stephens restated an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. JMP Securities restated a “market outperform” rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Friday, February 14th. Needham & Company LLC started coverage on Privia Health Group in a research report on Friday, January 10th. They set a “buy” rating and a $25.00 target price on the stock. Finally, Barclays lifted their target price on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. One research analyst has rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $25.18.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
- Five stocks we like better than Privia Health Group
- 3 REITs to Buy and Hold for the Long Term
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- What is Short Interest? How to Use It
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.